Alliance Management Consulting and Training, Partnering Frameworks and Tools, Collaborative Leadership

Overcoming the Challenges of Consensus Decision Making in Hybrid Environments at 2021 ASAP Biopharma Conference
4. News and Events / September 11th, 2021
The Rhythm of Business is proud to once again be a platinum sponsor of the ASAP Biopharma Conference. This is the premier event for life science alliance management professionals. Even in an all-digital format, there are plenty of opportunities to network, learn from industry leaders, and put your fingers on the pulse of partnerships today.

Jan Twombly and Jeff Shuman will lead a Live Stream Master Class session on Monday, September 27th: Operational Excellence for Consensus Decision Making in Hybrid Environments. Participants will analyze a comprehensive case study in small group discussions and address several questions to:
  • Apply leading practices for facilitating hybrid meetings to structure the decision-making process
  • Consider how to best prepare executives to properly consider a complex topic when not in a room together
  • Overcome the trust barriers that exist because alliance teams haven’t had the venues to properly build relationships during the pandemic
 
Participants’ analysis will be informed by an upfront presentation by Twombly and Shuman that shares some of their most recent work on driving excellence in alliance management practices in a hybrid environment and at a time when alliance management services are in high demand.
 
Twombly is a long-time member of the Board of Directors of ASAP. To see the complete Conference agenda and to register, visit https://asapbiopharma.org.
Rumblings, Perennial Challenges, and Reimagining a Path Forward
1. Partnering Guide / December 4th, 2020
There is no question 2020 has been the most challenging year in recent memory. As it comes to a welcome close, old challenges are appearing anew. For biopharmaceutical alliance professionals, it is once again the season of having to explain to the CFO wielding the budget axe, “So tell me again what you do?”
 
It is not surprising, given the uncertainty of the business climate and the wholesale changes that have occurred. Companies have learned to live without physicality in offices, sales calls, team meetings, conferences, new staff interviews…the list goes on and on. Suffice it to say that any executive worth their salt is examining what their business needs and doesn’t need to be successful as we hopefully emerge from the pandemic in 2021 and into the next normal.
 
Savvy alliance leaders should welcome the challenge—and be prepared with an answer that not only explains how you’ve helped the business achieve great things during 2020 by keeping its alliances on track. You must also be ready to share what you and your team are doing to reimagine the future course of the company’s alliance capability and help lead it in a time of scientific and technical advancement, changing economic incentives, and empowered patients that necessitates partnering happening everywhere in the organization—all while incorporating the surprisingly productive ways of doing business we’ve adopted...
The Silver Lining: Reimagining Alliance Management to Focus on What Matters Most Now
1. Partnering Guide / September 24th, 2020
Download a pdf of our conference presentation

Our hats are off to everyone who participated in the ASAP Biopharma Conference earlier this month! Because of all the creativity and engagement by speakers, participants, the program committee, and staff, it certainly felt like a real conference, just one delivered in a digital environment instead of in Boston’s Seaport District! It is further evidence the status quo is no more and so many of the old rules no longer apply. This is really the silver lining: a license to fix what’s broken, become more resourceful and agile, dispense with unnecessary process, and focus on what matters most.

COVID-19 and Work from Home (WFH) has created a new burden on alliance professionals. You must be more intentional, work harder to be in the right meetings, pay more attention to the mental and physical state of your team, your governance members. Add to this all the new types of service, data, and digital partnerships both before- and with-COVID and it is clear the time has come to reimagine how alliance management practices are implemented and the capability is organized and resourced to meet growing, changing demand.

Our presentation at the conference introduces practical actions for reimagining the collaboration between alliance managers and their internal stakeholders, especially governance team members, and the resulting partner experience. We toss aside the status quo to:
  • Redefine how alliance managers are assigned to alliances
  • Collaborate with stakeholders to align on the services that create value for them and that mitigate the panoply of value-eroding risks that are now present
  • Create the transparency of information flows and communication required in our together-but-apart world
Contact us today to discuss how our consulting and training services can help your alliance management team be more agile, more digital, and more successful in delivering the value to stakeholders that matters most today.
There is No Going Back: Roundtable Discussion Focuses on What Matters Most Now
4. News and Events / September 16th, 2020
A Summary of our ASAP 2020 Biopharma Conference Exclusive Executive Roundtable Discussion
 
It is really starting to settle in—there is no going back, there is only moving forward. Whenever we again experience a world where face-to-face meetings, quick drop-ins on a colleague or executive, and maybe even business travel are possible, there are some things we’ve learned in the past six months that make sense to carry forward into that next normal. In our current normal, we are not only figuring out how to deal with distanced work, we’re trying to learn how to innovate with new partners and new partnering models and ensure we deliver what matters most to our stakeholders and alliance partners to realize the outcomes and value intended by both newly formed alliances and those once operating under an entirely different set of assumptions.

These are some of the highlights of our exclusive executive roundtable discussion during the 2020 ASAP Biopharma Conference on September 15, complementing our presentation The Silver Lining: Reimagining Alliance Management to Focus on What Matters Most Now. Link to our conference presentat...
Reimagining Alliance Management for the Next Normal: ASAP Summit Virtual Executive Roundtable
4. News and Events / July 1st, 2020

Summary from exclusive ASAP Global Alliance Summit executive virtual roundtable. Download the discussion slides

“We are all operating in a new norm and we need to evolve with it.” So stated one of the alliance executives The Rhythm of Business invited to a virtual roundtable discussion during the 2020 ASAP Global Alliance Summit on reimagining alliance management for the next normal. We approached the topic from two angles:
 
  • The impact of COVID-19 on a people-intensive business that depends on good relationships
  • The increased demand for alliance management services as companies’ alliance portfolios continued to grow in size, complexity, and new types of digital and service alliances, even before the pandemic
The silver lining of needing to find a next normal is that it gives license to fix what is broken, it forces us to become more resourceful and agile, and focuses us on what...
Show a Little Alliance Management Love for Medical Affairs Presented at ASAP Biopharma Conference
4. News and Events / September 24th, 2019
Download a pdf of presentation

The 2019 ASAP Biopharma Conference is in full swing, with record attendance. The opening day included a session moderated by Jan Twombly, President, The Rhythm of Business on why collaboration between medical affairs teams in complex alliances is crucial and how alliance managers can be certain they are positioned for success, thereby increasing the likelihood the alliance will achieve its intended va...
How to Tame an Octopus: Managing the Proliferation of Clinical Collaborations
1. Partnering Guide / October 15th, 2018
In 2016, former US President Jimmy Carter announced that he no longer required treatment for his metastatic melanoma that had spread to his brain and liver. After six months of being treated with the immunotherapy pembrolizumab (trade name KEYTRUDA), together with surgery and radiation therapy, doctors had seen no sign of his disease for three months. This was a remarkable development—before pembrolizumab was approved in 2011, President Carter’s cancer likely would have been fatal.

Known as a “checkpoint inhibitor” pembrolizumab and other drugs in its class work—in simplest terms—by turbocharging the body’s immune system so that it can fight cancer. Its success, and the success of other similar drugs, such as avelumab (trade name BAVENCIO), and nivolumab (trade name OPDIVO), have unleashed a tsunami of clinical collaborations to identify how using these drugs in combination might expand and extend their significant patient benefits—and maximize their value to the biopharma companies that are de...
Taming the Octopus: Managing the Web of Clinical Collaborations
4. News and Events / July 1st, 2018
Jan Twombly, president of The Rhythm of Business is joined by Judy Baselice, director, alliance management at Pfizer and Ellen Locker, executive director, alliance management Merck & Co. at the 2018 ASAP Biopharma Conference in an interactive discussion about the complex web of agreements, restrictions, and obligations resulting from the explosion of clinical collaborations to create combination therapies....
Success through the Biopharma Channel at the ASAP Biopharma Conference
4. News and Events / September 1st, 2017

biopharma imageThe Rhythm of Business is pleased to once again announce our sponsorship of the ASAP Biopharma Conference, the leading conference for life science partnering professionals. This year, we are sharing some of our learning about driving commercial success with local partners, applying some of the lessons learned in the world of information technology.  

In high-tech, the last mile to the customer includes “channel partners” or “resellers.” This is also the case in biopharma – although it is rarely described as a channel.  Leveraging techniques high-tech companies have successfully utilized, we’ll examine practices biopharma companies are adopting to better align with their partners and drive success by ensuring their partners are successful.

Learn what it takes to make your company stand out and be top of mind when it comes to serving patients through the biopharma channel. Educate and engage key stakeholders in adopting your critical processes such as compliance, pharmacovigilance, supply chain, and quality. Help partners leverage your resources and achieve mutual success.

Learn more about the conference and register. It is an event not to be missed!

The Ubiquity of Partnering and Why Every Company Needs the Ability to Partner Everywhere
1. Partnering Guide / October 13th, 2016
AUTHORS: Jan Twombly and Jeff Shuman


Maybe it is starting to sink in. Just maybe it is starting to be understood. The ways and the depth with which we connect with others, connect our organizations, and share data, knowledge, and experience are driving business, societal, and personal value. This means managing external collaborative relationships well – a.k.a. partnerships and alliances – makes a difference in the outcomes we get!

Here are two recent studies that see the light: 

...
From Followers to Leaders: Alliance Management in Biopharma
2. Thought Leadership / November 22nd, 2012
download pdf
Author: Jan Twombly

For its 2012 study of alliance management in the biopharmaceutical industry, The Rhythm of Business surveyed 47 companies from across the globe and found that, on the whole, resources and staffs devoted to alliance management in biopharma are increasing or hol...
Top